These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Myocardial infarction induced by migraine therapy. George S; Vannozi Z Ann Emerg Med; 1995 May; 25(5):718-9. PubMed ID: 7741358 [No Abstract] [Full Text] [Related]
3. Life threatening intracerebral hemorrhage with isometheptene mucate, dichlorophenazine and acetaminophen combination therapy. Johnston JC J Forensic Leg Med; 2009 Nov; 16(8):489-91. PubMed ID: 19782324 [TBL] [Abstract][Full Text] [Related]
4. Autonomic dysreflexia due to medication: misadventure in the use of an isometheptene combination to treat migraine. Wineinger MA; Basford JR Arch Phys Med Rehabil; 1985 Sep; 66(9):645-6. PubMed ID: 4038034 [TBL] [Abstract][Full Text] [Related]
5. Migraine, Midrin, and Imitrex. Landy S; Richardson M; O'Quinn S Headache; 2002 Apr; 42(4):322-3; author reply 323-4. PubMed ID: 12010397 [No Abstract] [Full Text] [Related]
8. Phenelzine-induced fulminant hepatic failure. Gómez-Gil E; Salmerón JM; Mas A Ann Intern Med; 1996 Apr; 124(7):692-3. PubMed ID: 8607601 [No Abstract] [Full Text] [Related]
9. Seizures in a diabetic patient on monoamine oxidase inhibitors. Albareda M; Udina C; Escartín A; Corcoy R Am J Emerg Med; 1999 Jan; 17(1):107-8. PubMed ID: 9928719 [No Abstract] [Full Text] [Related]
10. Age effects on pupil dilation among Alzheimer's patients. Takagi A; Ishihara S; Kondo T; Sakakibara H; Toyoshima H; Kono K; Iguchi A; Yoshida F; Miyao M J Am Geriatr Soc; 1999 Feb; 47(2):257-8. PubMed ID: 9988302 [No Abstract] [Full Text] [Related]
11. Anaphylaxis after dichloralphenazone treatment. Perl S Br Med J; 1977 Nov; 2(6096):1187-8. PubMed ID: 589077 [No Abstract] [Full Text] [Related]
12. The hepatic injury of monoamine oxidase inhibitors. Zimmerman HJ; Ishak KG J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504 [No Abstract] [Full Text] [Related]
13. Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors. Smith SE; Lambourn J; Tyrer PJ Br J Clin Pharmacol; 1980 Jan; 9(1):21-5. PubMed ID: 7356888 [TBL] [Abstract][Full Text] [Related]
14. Migraine in older patients: a case report and management strategies. Rankin LM; Bruhl M Geriatrics; 2000 Jul; 55(7):70-4. PubMed ID: 10909408 [TBL] [Abstract][Full Text] [Related]
15. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. Tulen JH; Volkers AC; van den Broek WW; Bruijn JA J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207 [No Abstract] [Full Text] [Related]
16. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline. Fenwick MJ; Muwanga CL J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244 [TBL] [Abstract][Full Text] [Related]
17. Phenelzine Withdrawal-Associated Psychosis and Mania. Shao W; Brown T; Ayub S J Clin Psychopharmacol; 2017 Aug; 37(4):480-482. PubMed ID: 28609305 [No Abstract] [Full Text] [Related]
19. Not all monoamine oxidase inhibitors are created equal. Stewart JT J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910 [No Abstract] [Full Text] [Related]
20. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]